Emerson Announces Review of Operational, Capital Allocation and Portfolio Initiatives

Emerson (NYSE: EMR) today announced that it is conducting a comprehensive review of the Company’s operational, capital allocation and portfolio initiatives to enhance shareholder value and position the Company for both near- and long-term success. Emerson’s Board will lead the evaluation, which will be supported by a leading consulting firm and independent legal and financial advisors.